Meaningful Use Rule Clarification by John Halamka

Posted on July 28, 2010 I Written By

John Lynn is the Founder of the blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of and John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

In MedCity News, John Halamka makes an effort to summarize as simply as possible the Quality Measures:

I’ve been asked to summarize the Quality Measures as simply as possible

a. The Core Measures for All Eligible Professionals, Medicare and Medicaid are in the Final Rule Table 7, page 287. The Measures are

  • Hypertension: Blood Pressure Measurement
  • Tobacco Use Assessment and Tobacco Cessation Intervention
  • Adult Weight Screening and Follow-up

b. If the denominator for one or more of the Core Measures is zero, EPs will be required to report results for up to three Alternate Core Measures. The Alternate Core Measures for Eligible Professionals are in the Final Rule Table 7, page 287. The Measures are

  • Weight Assessment and Counseling for Children and Adolescents
  • Preventive Care and Screening: Influenza Immunization for Patients ? 50 Years Old
  • Childhood Immunization Status

c. The Clinical Quality Measures for Submission by Medicare or Medicaid EPs for the 2011 and 2012 Payment Year (EPs must choose 3) are in the Final Rule Table 6, page 272 . Here’s a summary of the 44 quality measures that CMS posted last week.

d. The Clinical Quality Measures for Submission by Eligible Hospitals and Critical Access Hospitals for Payment Year 2011-2012 are in the Final Rule Table 10, page 303. The Measures are

  • Emergency Department Throughput ’ admitted patients Median time from ED arrival to ED departure for admitted patients
  • Emergency Department Throughput ’ admitted patients Admission decision time to ED departure time for admitted patients
  • Ischemic stroke ’ Discharge on anti-thrombotics
  • Ischemic stroke ’ Anticoagulation for A-fib/flutter
  • Ischemic stroke ’ Thrombolytic therapy for patients arriving within 2 hours of symptom onset
  • Ischemic or hemorrhagic stroke ’ Antithrombotic therapy by day 2
  • Ischemic stroke ’ Discharge on statins
  • Ischemic or hemorrhagic stroke ’ Stroke education
  • Ischemic or hemorrhagic stroke ’ Rehabilitation assessment
  • VTE prophylaxis within 24 hours of arrival
  • Intensive Care Unit VTE prophylaxis
  • Anticoagulation overlap therapy
  • Platelet monitoring on unfractionated heparin
  • VTE discharge instructions
  • Incidence of potentially preventable VTE

Everything clear now?